Trans-Tasman Radiation Oncology Group

Trans-Tasman Radiation Oncology Group (TROG Cancer Research) is a leading clinical trials cooperative based in Australia and New Zealand, specializing in the field of radiation oncology. Established in 1989, the organization facilitates multicenter clinical trials to improve cancer treatment outcomes through innovative radiotherapy techniques and integrated treatment approaches. TROG collaborates with over 70 hospitals and cancer centers, as well as international research groups, to conduct high-impact studies that define global standards of care. Their research portfolio covers a broad spectrum of malignancies, including significant programs in prostate, breast, lung, and skin cancers. The group is recognized for its rigorous quality assurance programs and its role in advancing the technical and clinical application of radiation therapy.